Cargando…

Alternative CD44 splicing identifies epithelial prostate cancer cells from the mesenchymal counterparts

An epithelial to mesenchymal transition (EMT) has been shown to be a necessary precursor to prostate cancer metastasis. Additionally, the differential expression and splicing of mRNAs has been identified as a key means to distinguish epithelial from mesenchymal cells by qPCR, western blotting and im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hernandez, James R., Kim, John J., Verdone, James E., Liu, Xin, Torga, Gonzalo, Pienta, Kenneth J., Mooney, Steven M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2015
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391735/ https://www.ncbi.nlm.nih.gov/pubmed/25850653 http://dx.doi.org/10.1007/s12032-015-0593-z

Ejemplares similares

Glycolysis is the primary bioenergetic pathway for cell motility and cytoskeletal remodeling in human prostate and breast cancer cells
por: Shiraishi, Takumi, et al.
Publicado: (2014)

CD44V3, an Alternatively Spliced Form of CD44, Promotes Pancreatic Cancer Progression
por: Zhu, Hanzhang, et al.
Publicado: (2022)

Commentary: HNRNPLL, a newly identified colorectal cancer metastasis suppressor, modulates alternative splicing of CD44 during epithelial-mesenchymal transition
por: Baranwal, Somesh
Publicado: (2017)

High KIFC1 expression is associated with poor prognosis in prostate cancer
por: Kostecka, Laurie G., et al.
Publicado: (2021)

Uptake of prostate-specific membrane antigen-targeted (18)F-DCFPyL in avascular necrosis of the femoral head
por: Torga, Gonzalo, et al.
Publicado: (2019)

Aerobic glycolysis, motility, and cytoskeletal remodeling
por: Verdone, James E, et al.
Publicado: (2015)

Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer.
por: Gotley, D. C., et al.
Publicado: (1996)

The role of CD44 in epithelial–mesenchymal transition and cancer development
por: Xu, Hanxiao, et al.
Publicado: (2015)

OVOL guides the epithelial-hybrid-mesenchymal transition
por: Jia, Dongya, et al.
Publicado: (2015)

Molecular genetic characterization of alternatively spliced CD44 transcripts in human stomach carcinoma.
por: Kim, Y. S., et al.
Publicado: (1997)

Characteristics of CD44 alternative splice pattern in the course of human colorectal adenocarcinoma progression
por: Bánky, Balázs, et al.
Publicado: (2012)

Identifying global expression patterns and key regulators in epithelial to mesenchymal transition through multi-study integration
por: Parsana, Princy, et al.
Publicado: (2017)

Alternative splicing signatures discriminate ATL cells from untransformed CD4+ counterparts deriving from HTLV-1 infected individuals
por: Thenoz, Morgan, et al.
Publicado: (2014)

hnRNPK promotes gastric tumorigenesis through regulating CD44E alternative splicing
por: Peng, Wei-zhao, et al.
Publicado: (2019)

Stability of the hybrid epithelial/mesenchymal phenotype
por: Jolly, Mohit Kumar, et al.
Publicado: (2016)

The prostate metastasis suppressor gene NDRG1 differentially regulates cell motility and invasion
por: Sharma, Anup, et al.
Publicado: (2017)

Alternative Spliced CD1D Transcripts in Human Bronchial Epithelial Cells
por: Benam, Kambez Hajipouran, et al.
Publicado: (2011)

MAP kinase pathways and calcitonin influence CD44 alternate isoform expression in prostate cancer cells
por: Robbins, Eric W, et al.
Publicado: (2008)

MMP-14 and CD44 in Epithelial-to-Mesenchymal Transition (EMT) in ovarian cancer
por: Vos, Maria Caroline, et al.
Publicado: (2016)

Galangin inhibits epithelial-mesenchymal transition and angiogenesis by downregulating CD44 in glioma
por: Chen, Daliang, et al.
Publicado: (2019)

CD44 alternative splicing senses intragenic DNA methylation in tumors via direct and indirect mechanisms
por: Batsché, Eric, et al.
Publicado: (2021)

Identification of a comprehensive alternative splicing function during epithelial-mesenchymal transition
por: Qiu, Yushan, et al.
Publicado: (2023)

Technical challenges in the isolation and analysis of circulating tumor cells
por: van der Toom, Emma E., et al.
Publicado: (2016)

A bioinformatics approach reveals novel interactions of the OVOL transcription factors in the regulation of epithelial – mesenchymal cell reprogramming and cancer progression
por: Roca, Hernan, et al.
Publicado: (2014)

Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts
por: Liu, Suling, et al.
Publicado: (2013)

Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon
Publicado: (1995)

CD82 suppresses CD44 alternative splicing-dependent melanoma metastasis by mediating U2AF2 ubiquitination and degradation
por: Zhang, Pu, et al.
Publicado: (2016)

Regulation of Epithelial-Mesenchymal Transitions by Alternative Splicing: Potential New Area for Cancer Therapeutics
por: Li, Ling, et al.
Publicado: (2023)

A simple selection-free method for detecting disseminated tumor cells (DTCs) in murine bone marrow
por: Valkenburg, Kenneth C., et al.
Publicado: (2016)

Alternative Splicing Programs in Prostate Cancer
por: Sette, Claudio
Publicado: (2013)

DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis()
por: Lee, Eunsohl, et al.
Publicado: (2016)

Epithelial-To-Mesenchymal Transition Markers and CD44 Isoforms Are Differently Expressed in 2D and 3D Cell Cultures of Prostate Cancer Cells
por: Fontana, Fabrizio, et al.
Publicado: (2019)

CD44 Staining of Cancer Stem-Like Cells Is Influenced by Down-Regulation of CD44 Variant Isoforms and Up-Regulation of the Standard CD44 Isoform in the Population of Cells That Have Undergone Epithelial-to-Mesenchymal Transition
por: Biddle, Adrian, et al.
Publicado: (2013)

Identification of CD44 splice variant in Korean colorectal cancers and cell lines.
por: Suh, S. I., et al.
Publicado: (1995)

Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons
Publicado: (1995)

Tax promotes the expression of the alternative spliced isoform CD44v10 by slowing down the elongating RNA polymerase II
por: Thenoz, Morgan, et al.
Publicado: (2014)

Alternative splicing in mesenchymal stem cell differentiation
por: Park, Jung Woo, et al.
Publicado: (2020)

A spliced form of CD44 expresses the unique glycan that is recognized by the prostate cancer specific antibody F77
por: Chen, Xi, et al.
Publicado: (2017)

Cancer dormancy and criticality from a game theory perspective
por: Wu, Amy, et al.
Publicado: (2018)

Epithelial‐mesenchymal transition is activated in CD44‐positive malignant ascites tumor cells of gastrointestinal cancer
por: Nakano, Michitaka, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cbktkvlocpikfnkdp62ne23k54